Evidence map›Paper›PMID 36315503›Full record

ArticlePLoS neglected tropical diseases2022

Modeling the efficacy of CRISPR gene drive for snail immunity on schistosomiasis control.

Richard E Grewelle, Javier Perez-Saez, Josh Tycko, Erica K O Namigai, Chloe G Rickards, Giulio A De Leo

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. CRISPR/Cas9-germline editing ofScience advances · 2025
    Article
  3. Article
  4. Applications of CRISPR in Parasitology.Current pharmaceutical biotechnology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. PeerJ · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Richard E GrewelleDepartment of Biology, Stanford University, Stanford, California, United States of America.ORCID 0000-0002-6432-1423
Javier Perez-SaezDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
Josh TyckoDepartment of Genetics, Stanford University, Stanford, California, United States of America.
Erica K O NamigaiDepartment of Zoology, University of Oxford, Oxford, United Kingdom.
Chloe G RickardsDepartment of Biology, University of California Santa Cruz, Santa Cruz, California, United States of America.
Giulio A De LeoDepartment of Biology, Stanford University, Stanford, California, United States of America.ORCID 0000-0002-4186-3369
Johns Hopkins University · USPacific University · USPalo Alto Institute · USStanford University · USUniversity of California, Santa Cruz · USUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CRISPR gene drives could revolutionize the control of infectious diseases by accelerating the spread of engineered traits that limit parasite transmission in wild populations. Gene drive technology in mollusks has received little attention despite the role of freshwater snails as hosts of parasitic flukes causing 200 million annual cases of schistosomiasis. A successful drive in snails must overcome self-fertilization, a common feature of host snails which could prevents a drive's spread. Here we developed a novel population genetic model accounting for snails' mixed mating and population dynamics, susceptibility to parasite infection regulated by multiple alleles, fitness differences between genotypes, and a range of drive characteristics. We integrated this model with an epidemiological model of schistosomiasis transmission to show that a snail population modification drive targeting immunity to infection can be hindered by a variety of biological and ecological factors; yet under a range of conditions, disease reduction achieved by chemotherapy treatment of the human population can be maintained with a drive. Alone a drive modifying snail immunity could achieve significant disease reduction in humans several years after release. These results indicate that gene drives, in coordination with existing public health measures, may become a useful tool to reduce schistosomiasis burden in selected transmission settings with effective CRISPR construct design and evaluation of the genetic and ecological landscape.

Indexed as

Gene Drive TechnologySchistosomiasisAnimalsChinaClustered Regularly Interspaced Short Palindromic RepeatsFresh WaterHumansSnails

Identifiers

PMID36315503
PMCPMC9648845
OpenAlexW4307699375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.